Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN63,6963,72-0,14
Msft1,64
Nokia3,40253,538-0,07
IBM-0,12
Mercedes-Benz Group AG62,8662,880,10
PFE1,95
27.07.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 26.07.2024 22:00:00
Bruker Bioscien (BRKR.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
66,81 4,02 2,58 1 200 414
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 27.07.2024
Popis společnosti

Business Summary: Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company’s BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It offers scanning transmission electron microscopes (STEM). It also offers advanced research Raman microscopy systems.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Bruker Corp revenues increased 17% to $2.96B. Net income increased 44% to $427.2M. Revenues reflect BSI NANO segment increase of 20% to $941.9M, BSI CALID segment increase of 17% to $960.4M, BSI BioSpin segment increase of 15% to $798.5M, China segment increase of 33% to $528.1M, Europe segment increase of 18% to $699.7M, United States segment increase of 12% to $777.7M.



  • Poslední aktualizace: 27.07.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Managing Director, Executive Director of Almancora Societe de gestionMarc De Ceuster6118.05.202318.05.2023
Managing Director, Executive Director, Permanent Representative of Almancora Societe de gestionFranky Depickere6515.09.200615.09.2006